Detecting thrombophilia in ob/gyn patients

Contemporary Ob/Gyn

Volumn 47, Issue 10, 2002, Pages 68-86

  Katz, Vern L ^a  

^a Sacred Heart Medical Center Eugene   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949961805     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
2. Lockwood CJ. Inherited thrombophilias in pregnancy patients: detection and treatment paradigm. Obstet Gynecol. 2002:99:333-341.
3. Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343:1015-1018.
4. Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost. 1999;82:634-640.
5. Walker ID. Thrombophilia in pregnancy. J Clin Pathol. 2000;53:573-580.
6. Gerhardt A, Scharf RE. Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374-380.
7. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344;1222.
8. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995; 346:1133-1134.
9. Glueck CJ, Phillips H, Cameron D. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism. 2000;49:845-852.
10. McColl MD, Walker ID, Greer IA. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol. 1999;106:756-766.
11. Ridker PM, Glynn RJ. Miletich JP, et al. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med. 1997;126:528-531.
12. Many A, Schreiber L, Rosner S, et al. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol. 2001 98:1041-1044.
13. Bakker RC, Brandjes DP. Hyperhomocysteinaemia and associated disease. Pharm World Sci. 1997;19:126-132.
14. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407-413.
15. Van der Molen EF, Arends G, Nelen WL, et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol. 2000;182:1258-1263.
16. Dean JC, Moore SJ, Osborne A, et al. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet. 1999;56:216-220.
17. Steegers-Theunissen RP, Boers GH, Trijbels JM, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994;43:1475-1480.